Eribulin EVER Pharma

Medicinal product

(Invented) name

Eribulin EVER Pharma

Active substance (s)

Eribulinas

Strength

0,44 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XX41, Eribulin

Marketing authorisation holder

Ever Valinject GmbH, Austrija

Date of authorisation

2024-04-24

Date of renewal

Documents

5413 Eribulin EVER Pharma.docx

5413 pakuotes lapelis_2024-04-24.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

PT/H/2825/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml tirpalo yra:	1 ml
Eribulinas	0,44 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113469	99587	1099587	flakonas	2 ml N1		Receptinis	LT/1/24/5413/001	Netiekiama	-	-	No	-	-
113470	99588	1099588	flakonas	2 ml N6		Receptinis	LT/1/24/5413/002	Netiekiama	-	-	No	-	-
113471	99589	1099589	flakonas	3 ml N1		Receptinis	LT/1/24/5413/003	Netiekiama	-	-	No	-	-
113472	99590	1099590	flakonas	3 ml N6		Receptinis	LT/1/24/5413/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-04-24	Registruotas